| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6745012
[patent_doc_number] => 20030022195
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => '59914 and 59921, choline transporters and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/062937
[patent_app_country] => US
[patent_app_date] => 2002-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 45904
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 182
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20030022195.pdf
[firstpage_image] =>[orig_patent_app_number] => 10062937
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/062937 | 59914 and 59921, choline transporters and uses therefor | Jan 30, 2002 | Abandoned |
Array
(
[id] => 979164
[patent_doc_number] => 06930168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-16
[patent_title] => 'Synthetic peptides for demyelinating conditions'
[patent_app_type] => utility
[patent_app_number] => 10/056583
[patent_app_country] => US
[patent_app_date] => 2002-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 14367
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/930/06930168.pdf
[firstpage_image] =>[orig_patent_app_number] => 10056583
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/056583 | Synthetic peptides for demyelinating conditions | Jan 23, 2002 | Issued |
| 09/868418 | Soluble haemopoietin receptor nr6 (clf-1) and uses thereof | Jan 14, 2002 | Abandoned |
Array
(
[id] => 782812
[patent_doc_number] => 06992060
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-01-31
[patent_title] => 'Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes'
[patent_app_type] => utility
[patent_app_number] => 10/044048
[patent_app_country] => US
[patent_app_date] => 2002-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 9
[patent_no_of_words] => 7643
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/992/06992060.pdf
[firstpage_image] =>[orig_patent_app_number] => 10044048
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/044048 | Prolonged efficacy of islet neogenesis therapy methods with a gastrin/CCK receptor ligand and an EGF receptor ligand composition in subjects with preexisting diabetes | Jan 10, 2002 | Issued |
Array
(
[id] => 6846892
[patent_doc_number] => 20030166059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => '54498, an amino acid transporter and uses therefor'
[patent_app_type] => new
[patent_app_number] => 10/044897
[patent_app_country] => US
[patent_app_date] => 2002-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 41151
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10044897
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/044897 | 54498, an amino acid transporter and uses therefor | Jan 9, 2002 | Abandoned |
Array
(
[id] => 657612
[patent_doc_number] => 07105167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-12
[patent_title] => 'Methods for treating clinical manifestations of GH/GF axis dysregulation by administration of an IGF-I variant'
[patent_app_type] => utility
[patent_app_number] => 10/028410
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 23674
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105167.pdf
[firstpage_image] =>[orig_patent_app_number] => 10028410
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/028410 | Methods for treating clinical manifestations of GH/GF axis dysregulation by administration of an IGF-I variant | Dec 18, 2001 | Issued |
Array
(
[id] => 6821577
[patent_doc_number] => 20030219738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-11-27
[patent_title] => 'Nucleic acid and encoded zinc transporter protein entitled 108P5H8 useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/024652
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 99356
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0219/20030219738.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024652
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024652 | Antibody that binds zinc transporter protein 108P5H8 | Dec 16, 2001 | Issued |
Array
(
[id] => 6710969
[patent_doc_number] => 20030170718
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/017306
[patent_app_country] => US
[patent_app_date] => 2001-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 283259
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170718.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017306
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017306 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 12, 2001 | Abandoned |
Array
(
[id] => 6683233
[patent_doc_number] => 20030119097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/020063
[patent_app_country] => US
[patent_app_date] => 2001-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 279605
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20030119097.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020063
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020063 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 12, 2001 | Abandoned |
Array
(
[id] => 6664728
[patent_doc_number] => 20030204054
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/015394
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 279737
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20030204054.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015394
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015394 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 10, 2001 | Abandoned |
Array
(
[id] => 6870772
[patent_doc_number] => 20030083462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-01
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/013913
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 279504
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0083/20030083462.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013913
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013913 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 9, 2001 | Abandoned |
Array
(
[id] => 5787219
[patent_doc_number] => 20020160475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Novel human ion channel protein and polynucleotides encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/016647
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9007
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160475.pdf
[firstpage_image] =>[orig_patent_app_number] => 10016647
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/016647 | Novel human ion channel protein and polynucleotides encoding the same | Dec 9, 2001 | Abandoned |
Array
(
[id] => 6856990
[patent_doc_number] => 20030130491
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/015822
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 279665
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20030130491.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015822 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 9, 2001 | Abandoned |
Array
(
[id] => 6731003
[patent_doc_number] => 20030187193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-02
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/013911
[patent_app_country] => US
[patent_app_date] => 2001-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 283379
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0187/20030187193.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013911
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013911 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 9, 2001 | Abandoned |
Array
(
[id] => 6847713
[patent_doc_number] => 20030166880
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-04
[patent_title] => '57304, a novel human organic cation transporter and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/989753
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 38980
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0166/20030166880.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989753
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989753 | 57304, a novel human organic cation transporter and uses thereof | Nov 19, 2001 | Abandoned |
Array
(
[id] => 6735501
[patent_doc_number] => 20030013136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-16
[patent_title] => 'Human KCR1 regulation of HERG potassium channel block'
[patent_app_type] => new
[patent_app_number] => 10/000151
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 41752
[patent_no_of_claims] => 99
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20030013136.pdf
[firstpage_image] =>[orig_patent_app_number] => 10000151
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/000151 | Human KCR1 regulation of HERG potassium channel block | Oct 29, 2001 | Abandoned |
Array
(
[id] => 6473191
[patent_doc_number] => 20020151492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-17
[patent_title] => 'Testis specific protein'
[patent_app_type] => new
[patent_app_number] => 10/001632
[patent_app_country] => US
[patent_app_date] => 2001-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35303
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0151/20020151492.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001632
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001632 | Testis specific protein | Oct 24, 2001 | Abandoned |
| 09/926234 | Peptides useful in treating multiple sclerosis and a pharmaceutical composition comprising the same | Oct 21, 2001 | Abandoned |
Array
(
[id] => 5985831
[patent_doc_number] => 20020098521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-25
[patent_title] => 'Method and marker for the isolation of human multipotent hematopoietic stem cells'
[patent_app_type] => new
[patent_app_number] => 09/982473
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5895
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0098/20020098521.pdf
[firstpage_image] =>[orig_patent_app_number] => 09982473
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/982473 | Method and marker for the isolation of human multipotent hematopoietic stem cells | Oct 17, 2001 | Abandoned |
Array
(
[id] => 6750941
[patent_doc_number] => 20030045462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/978608
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192040
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045462.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978608 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 15, 2001 | Abandoned |
